ITPD920073A1 - Metodo per la preparazione e purificazione di miscele di fosfolipidi prive di contaminanti da virus non convenzionali - Google Patents

Metodo per la preparazione e purificazione di miscele di fosfolipidi prive di contaminanti da virus non convenzionali

Info

Publication number
ITPD920073A1
ITPD920073A1 IT000073A ITPD920073A ITPD920073A1 IT PD920073 A1 ITPD920073 A1 IT PD920073A1 IT 000073 A IT000073 A IT 000073A IT PD920073 A ITPD920073 A IT PD920073A IT PD920073 A1 ITPD920073 A1 IT PD920073A1
Authority
IT
Italy
Prior art keywords
phospholipids
contaminants
purification
mixtures
preparation
Prior art date
Application number
IT000073A
Other languages
English (en)
Inventor
Lanfranco Callegaro
Martino Alessandro Di
Gino Toffano
Original Assignee
Fidia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Spa filed Critical Fidia Spa
Priority to ITPD920073A priority Critical patent/IT1260149B/it
Publication of ITPD920073A0 publication Critical patent/ITPD920073A0/it
Priority to EP93911469A priority patent/EP0638083B1/en
Priority to PCT/EP1993/000915 priority patent/WO1993021190A1/en
Priority to DE69308834T priority patent/DE69308834D1/de
Priority to AT93911469T priority patent/ATE150025T1/de
Publication of ITPD920073A1 publication Critical patent/ITPD920073A1/it
Application granted granted Critical
Publication of IT1260149B publication Critical patent/IT1260149B/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/10Phosphatides, e.g. lecithin
    • C07F9/103Extraction or purification by physical or chemical treatment of natural phosphatides; Preparation of compositions containing phosphatides of unknown structure

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
ITPD920073A 1992-04-17 1992-04-17 Metodo per la preparazione e purificazione di miscele di fosfolipidi prive di contaminanti da virus non convenzionali IT1260149B (it)

Priority Applications (5)

Application Number Priority Date Filing Date Title
ITPD920073A IT1260149B (it) 1992-04-17 1992-04-17 Metodo per la preparazione e purificazione di miscele di fosfolipidi prive di contaminanti da virus non convenzionali
EP93911469A EP0638083B1 (en) 1992-04-17 1993-04-16 Method for the preparation and purification of phospholipid mixtures free from contamination by unconventional viruses
PCT/EP1993/000915 WO1993021190A1 (en) 1992-04-17 1993-04-16 Method for the preparation and purification of phospholipid mixtures free from contamination by unconventional viruses
DE69308834T DE69308834D1 (de) 1992-04-17 1993-04-16 Verfahren zur herstellung und reinigung von phospholipidmischungen frei von kontaminierenden unkonventionellen viren
AT93911469T ATE150025T1 (de) 1992-04-17 1993-04-16 Verfahren zur herstellung und reinigung von phospholipidmischungen frei von kontaminierenden unkonventionellen viren

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITPD920073A IT1260149B (it) 1992-04-17 1992-04-17 Metodo per la preparazione e purificazione di miscele di fosfolipidi prive di contaminanti da virus non convenzionali

Publications (3)

Publication Number Publication Date
ITPD920073A0 ITPD920073A0 (it) 1992-04-17
ITPD920073A1 true ITPD920073A1 (it) 1993-10-17
IT1260149B IT1260149B (it) 1996-03-28

Family

ID=11389905

Family Applications (1)

Application Number Title Priority Date Filing Date
ITPD920073A IT1260149B (it) 1992-04-17 1992-04-17 Metodo per la preparazione e purificazione di miscele di fosfolipidi prive di contaminanti da virus non convenzionali

Country Status (5)

Country Link
EP (1) EP0638083B1 (it)
AT (1) ATE150025T1 (it)
DE (1) DE69308834D1 (it)
IT (1) IT1260149B (it)
WO (1) WO1993021190A1 (it)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2714574B1 (fr) * 1993-12-31 1996-03-15 Inst Rech Biolog Sa Nouveaux suppléments alimentaires pour la nutrition des très jeunes enfants.
FR2721516B1 (fr) * 1994-06-27 1996-09-13 Inst Rech Biolog Sa Nouvelles utilisations d'un complexe à base de phospholipides cérébraux en thérapeutique et dans l'alimentation.
FR2736265B1 (fr) * 1995-07-07 1997-09-26 Forgeot Marcel Nouvelles compositions a base de phosphoglycero ethers et leur utilisation dans le traitement des maladies neuro-degeneratives
ATE215387T1 (de) * 1996-03-15 2002-04-15 Aventis Pasteur Verfahren zum entfernen von unkonventionellen krankheitserregern aus proteinlösungen
FR2746030B1 (fr) * 1996-03-15 1998-04-17 Procede pour eliminer les agents transmissibles non conventionnels (atnc) d'une solution d'albumine
FR2750887B1 (fr) * 1996-07-09 1998-10-23 Imedex Procede d'elimination des agents transmissibles non conventionnels (atnc) d'une solution proteique
WO2003088949A2 (de) * 2002-04-19 2003-10-30 Bioghurt Biogarde Gmbh & Co. Kg. Matrix mit einer bioaktiven phospholipid-haltigen komponente
DE10250727B4 (de) * 2002-04-19 2008-07-10 Cargill, Incorporated, Wayzata Matrix mit einer bioaktiven Phospholipid-haltigen Komponente
ITPD20050164A1 (it) * 2005-05-30 2006-11-30 Fidia Farmaceutici Processo per la preparazione e l'isolamento di fosfatidi
IT202100032252A1 (it) 2021-12-22 2023-06-22 Fidia Farm Spa Processo di estrazione e purificazione industriale di fosfolipidi
CN115010748B (zh) * 2022-05-27 2023-10-20 扬州大学 硅胶柱层析同时分离纯化磷脂酰胆碱和鞘磷脂的方法
CN114989212A (zh) * 2022-05-27 2022-09-02 广州白云山汉方现代药业有限公司 一种天然鞘磷脂的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1212900B (it) * 1983-11-17 1989-11-30 Valle Francesco Della Uso terapeutico della fosfatidilserina in malattie del sistema nervoso centrale senza effetti sulla coagulazione sanguigna
ES528692A0 (es) * 1984-01-04 1985-07-01 Bioiberica Procedimiento para la obtencion de un complejo glicoesfingolipidico
NZ236059A (en) * 1989-11-17 1993-03-26 Fidia Spa Extraction of gangliosides

Also Published As

Publication number Publication date
ATE150025T1 (de) 1997-03-15
EP0638083A1 (en) 1995-02-15
ITPD920073A0 (it) 1992-04-17
WO1993021190A1 (en) 1993-10-28
IT1260149B (it) 1996-03-28
DE69308834D1 (de) 1997-04-17
EP0638083B1 (en) 1997-03-12

Similar Documents

Publication Publication Date Title
ITPD920073A1 (it) Metodo per la preparazione e purificazione di miscele di fosfolipidi prive di contaminanti da virus non convenzionali
ES2122218T3 (es) Procedimiento de separacion de una composicion polidispersada de sacaridos.
PT731812E (pt) Metodo para isolar poli-beta-1-4-n-acetilglucosamina
UA39135C2 (uk) Спосіб фракціонування розчину
MX23889A (es) Derivados de cromanos y tiocromanos, procedimiento para su preparacion y composicion farmaceutica.
BR9810002A (pt) Preparação de <244>1-at nativa purificada cromatograficamente, processo para a preparação da mesma, e, utilização de um material de suporte
KR890700021A (ko) 인지질 조성물
BR0209081A (pt) Processo de remoção de produto e sistema de remoção de produto in situ
BR122012018280B8 (pt) composição farmacêutica compreendendo hormônio luteinizante humano e sacarose
KR880003975A (ko) 항응고성 및 항전이성을 갖는 단백질
ATE509028T1 (de) Ionen-austausch-chromatographische trennung von glp-1 und verwandten peptiden
ES2169384T3 (es) Procedimiento cromatografico para la obtencion de ciclosporina a altamente purificada y ciclosporinas analogas.
ATE207930T1 (de) Gereinigtes gp120, in dem seine natürliche konformation erhalten bleibt
Zlotkin et al. A protein toxic to crustacea from the venom of the scorpion Androctonus australis
DK0396022T3 (da) Fremgangsmåde til isolering af blodkoagulationsfaktor IX
BR0212260A (pt) Agente antimicrobiano
El Asmar et al. Fractionation of scorpion (Leiurus quinquestriatus H and E) venom
Lucca et al. Influence of cell culture conditions on the protective effect of antioxidants against β-amyloid toxicity: studies with lazaroids
AHMED et al. Purification of a sialic acid-specific lectin from the Indian scorpion Heterometrus granulomanus
Hearn et al. The Analysis of Insulin-Related Peptides by Reversed-Phase High-Performance Liquid Chromatography
KR950013519A (ko) 골절 예방 및 치료용 약제
Araujo et al. Potentiation of bradykinin action on smooth muscle by a scorpion venom extract
DK0536564T3 (da) Fremgangsmåde til fremstilling af streptolysin O, intakt streptolysin O fremstillet ved denne fremgangsmåde og dets anvendelse
MY113294A (en) A process for the preparation of a virus inactivated fraction containing factor viii by means of chromatographic methods
Iwase et al. Subfractionation of the dansylated derivatives of glucosyl galactosyl hydroxylysine by liquid chromatography and its application to a specific α-1, 2-glucosidase assay

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970131